Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-086420
Filing Date
2025-06-13
Accepted
2025-06-13 18:30:08
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3187
  Complete submission text file 0000950170-25-086420.txt   4629
Mailing Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111 (415) 432-9270
89bio, Inc. (Issuer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address
Martins Ryan (Reporting) CIK: 0001792018 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39122 | Film No.: 251048020